Xvivo Perfusion AB/Skr XVIVO
07:00
09:05
11:15
13:20
15:25
1D1W1MYTD1Y5YMAX
About Xvivo Perfusion AB
Xvivo Perfusion AB is a biotechnology company specializing in the development and commercialization of medical devices and systems for organ transplantation. The company's core products include machine perfusion devices and solutions designed to preserve, evaluate, and transport donor organs, with a particular focus on lungs and hearts. Founded in 1998, Xvivo is headquartered in Gothenburg, Sweden, and has established a presence in key markets worldwide. The company's strategic positioning is enhanced by its commitment to improving transplantation outcomes through innovative technologies and research collaborations. Xvivo's expertise in organ preservation and perfusion technology provides competitive strengths in the field of regenerative medicine.
Ticker
Skr XVIVO
Sector
Primary listing
XSTO
Employees
197
Headquarters
Mölndal, Sweden
Website
XVIVO Metrics
BasicAdvanced
kr 8.3bn
93.89
kr 2.81
1.46
-
Price and volume
Market cap
kr 8.3bn
Beta
1.46
52-week high
kr 310.40
52-week low
kr 160.00
Average daily volume
66k
Financial strength
Current ratio
3.86
Quick ratio
2.653
Long term debt to equity
4.996
Total debt to equity
5.528
Profitability
EBITDA (TTM)
158.26
Gross margin (TTM)
72.27%
Net profit margin (TTM)
9.89%
Operating margin (TTM)
13.15%
Effective tax rate (TTM)
32.65%
Revenue per employee (TTM)
kr 4,540,000
Management effectiveness
Return on assets (TTM)
2.99%
Return on equity (TTM)
4.13%
Valuation
Price to earnings (TTM)
93.89
Price to revenue (TTM)
9.289
Price to book
3.78
Price to tangible book (TTM)
5.44
Price to free cash flow (TTM)
-1,100.564
Free cash flow yield (TTM)
-0.09%
Free cash flow per share (TTM)
-0.24
Growth
Revenue change (TTM)
8.79%
Earnings per share change (TTM)
-19.96%
3-year revenue growth (CAGR)
19.58%
10-year revenue growth (CAGR)
21.54%
3-year earnings per share growth (CAGR)
45.50%
10-year earnings per share growth (CAGR)
24.66%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.